Dual regulatory effects of resveratrol on activation of NF-κB and cell proliferation in human embryonal kidney 293 cells

Chinese Science Bulletin

Volumn 50, Issue 8, 2005, Pages 770-774

  Yin, Hong ^a   Cheng, Guifang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cell cycle; Cell proliferation; HEK293; IL 8; NF B activation; Resveratrol

Indexed keywords

EID: 33749666180     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/982005-57     Document Type: Article

References (24)

1. Langcake, P., Pryce, R. J., The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury, Physiol. Plant Pathol., 1976, 9: 77-86.
2. Gusman, J., Malonne, H., Atasst, G., A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol, Carcinogenesis, 2001, 22(8): 1111-1117.
3. Aziz, M. H., Kumar, R., Ahmad, N., Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms, Int. J. Oncol., 2003, 23(1): 17-28.
4. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S. et al., Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies, Anticancer Res., 2004, 24(5A): 2783-2840.
5. Howitz, K. T., Bitterman, K. J., Cohen, H. Y. et al., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature, 2003, 425(6954): 191-196.
6. Culpitt, S. V., Rogers, D. F., Fenwick, P. S. et al., Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD, Thorax., 2003, 58(11): 942-946.
7. Corder, R., Crozier, A., Kroon, P. A., Drinking your health? It's too early to say, Nature, 2003, 426(6963): 119.
8. Goldberg, D. M., Van, J., Soleas, G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects, Clin. Biochem., 2003, 36(1): 79-87.
9. Crowell, J. A., Korytko, P. J., Morrissey, R. L. et al., Resveratrol associated renal toxicity, Toxicol. Sci., 2004, 82(2): 614-619.
10. Kucharczak, J., Simmons, M. J., Fan, Y. et al., To be, or not to be: NF-κB is the answer-Role of Rel/NF-kappaB in the regulation of apoptosis, Oncogene, 2003, 22(56): 8961-8982.
11. Estrov, Z., Shishodia, S., Faderl, S. et al., Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells, Blood, 2003, 102(3): 987-995.
12. Takada, Y., Bhardwaj, A., Potdar, P. et al., Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation, Oncogene, 2004, 23(57): 9247-9258.
13. Manna, S. K., Mukhopadhyay, A., Aggarwal, B. B., Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-κB, Activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation, J. Immunol., 2000, 164(12): 6509-6519.
14. Donnelly, L. E., Newton, R., Kennedy, G. E. et al., Anti-inflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms, Am. J. Physiol. Lung Cell Mol. Physiol., 2004, 287(4): L774-783.
15. Yin, H., Cheng, G. F., Anti-inflammatory drugs differ in their abilities to regulate NF-κB activation, Acta Pharm. Sin., 2005, 40(6): 491-495.
16. Xiong, X. Y., Wu, Y. M., Zou, Y. et al., Comparison of effects of three drugs for Alzheimer's disease on viability of mouse cortical neurons in vitro. Chin. J. Clin. Pharmacol. Ther., 2004, 9(4): 399-402.
17. Boscolo, P., del Signore, A., Sabbioni, E. et al., Effects of resveratrol on lymphocyte proliferation and cytokine release, Ann. Clin. Lab. Sci., 2003, 33(2): 226-231.
18. Fulda, S., Debatin, K. M., Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol, Oncogene, 2004, 23(40): 6702-6711.
19. Fuggetta, M. P., D'Atri, S., Lanzilli, G. et al., In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide, Melanoma Res., 2004, 14(3): 189-196.
20. Harper, N., Farrow, S. N., Kaptein, A. et al., Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-κB activation by inhibition of apical caspases, J. Biol. Chem., 2001, 276(37): 34743-34752.
21. Pellegatta, F., Bertelli, A. A., Staels, B. et al., Different short- and long-term effects of resveratrol on nuclear factor-κB phosphorylation and nuclear appearance in human endothelial cells, Am. J. Clin. Nutr., 2003, 77(5): 1220-1228.
22. Jeong, W. S., Kim, I. W., Hu, R. et al., Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway, Pharm. Res., 2004, 21(4): 661-670.
23. Shen, F., Chen, S. J., Dong, X. J. et al., Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells, J. Asian Nat. Prod. Res., 2003, 5(2): 151-157.
24. Imamura, R., Konaka, K., Matsumoto, N. et al., Fas ligand induces cell-autonomous NF-κ activation and IL-8 production by a mechanism distinct from that of TNF-alpha, J. Biol. Chem., 2004, 279(45): 46415-46423.